JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M404568200 on June 10, 2004

J. Biol. Chem., Vol. 279, Issue 35, 36287-36292, August 27, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/35/36287    most recent
M404568200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maliekal, T. T.
Right arrow Articles by Karunagaran, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maliekal, T. T.
Right arrow Articles by Karunagaran, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Activation of Smads in HeLa and SiHa Cells That Differ in Their Response to Transforming Growth Factor-{beta}*

Tessy T. Maliekal, Ruby John Anto, and Devarajan Karunagaran{ddagger}

From the Division of Cancer Biology, Rajiv Gandhi Center for Biotechnology, Thiruvananthapuram, Kerala 695 014, India

We assessed the responsiveness of six human cervical cancer cell lines to transforming growth factor (TGF)-{beta} with p3TP-lux reporter assay and found that HeLa and SiHa cells were highly responsive to TGF-{beta}. However, when pSBE4-BV/Luc reporter with four Smad binding elements was used, only the SiHa, not the HeLa, cells showed Smad activation. Smad DNA binding activity was relatively more in SiHa than in HeLa cells upon TGF-{beta} treatment, and the active complex contained Smad 2 and Smad 4. In 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, HeLa cells treated with 5 ng/ml of TGF-{beta} for 24 h showed proliferation, whereas SiHa cells showed growth inhibition under the same conditions. TGF-{beta} treatment resulted in G0/G1 arrest with a reduction in S-phase only in SiHa cells. A chemical inhibitor of Smad activation (SB203580) blocked the growth inhibitory effect of TGF-{beta} in SiHa, whereas the proliferative response in HeLa was unaffected. TGF-{beta}-induced translocation of phospho-Smad 2 was relatively less in HeLa than in SiHa cells. MAPK activation occurred within 5 min and persisted up to 15 min upon TGF-{beta} treatment in HeLa but was negligible in SiHa cells. TGF-{beta} activated JNK in HeLa, but SiHa cells showed a down-regulation of its activity. When an inhibitor of MAPK (U0126) was used, the TGF-{beta}-mediated proliferative response in HeLa cells was completely abolished. SB203580 did not affect MAPK activation induced by TGF-{beta} in HeLa cells. We report for the first time an activation, presumably independent of Smad activation, of TGF-{beta}-dependent MAPK within 5 min of treatment that resulted in cell cycle progression in a cervical adenocarcinoma cell line, HeLa.


Received for publication, April 26, 2004 , and in revised form, June 10, 2004.

* This work was supported by a research grant from the Department of Science and Technology (to D. K.), by program support to the Rajiv Gandhi Center from the Department of Biotechnology, and by a senior research fellowship (to T. T. M.) from the Council of Scientific and Industrial Research, Government of India. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} To whom correspondence should be addressed. Tel.: 91-471-2347975; Fax: 91-471-2348096; E-mail: dkarunagaran{at}hotmail.com.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
R. Ren, P. C. Charles, C. Zhang, Y. Wu, H. Wang, and C. Patterson
Gene expression profiles identify a role for cyclooxygenase 2-dependent prostanoid generation in BMP6-induced angiogenic responses
Blood, April 1, 2007; 109(7): 2847 - 2853.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. M. Stuhlmeier and C. Pollaschek
Adenovirus-mediated Gene Transfer of Mutated I{kappa}B Kinase and I{kappa}B{alpha} Reveal NF-{kappa}B-dependent as Well as NF-{kappa}B-independent Pathways of HAS1 Activation
J. Biol. Chem., December 30, 2005; 280(52): 42766 - 42773.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. N. Kloth, G. J. Fleuren, J. Oosting, R. X. de Menezes, P. H.C. Eilers, G. G. Kenter, and A. Gorter
Substantial changes in gene expression of Wnt, MAPK and TNF{alpha} pathways induced by TGF-{beta}1 in cervical cancer cell lines
Carcinogenesis, September 1, 2005; 26(9): 1493 - 1502.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.